genOway Société anonyme (EPA:ALGEN)
France · Delayed Price · Currency is EUR 2.410
-0.030 (-1.23%)
Aug 3, 2026, 2:04 PM CET
genOway Société anonyme Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 22 | 18 | 36 | 43 | 36 | 39 | |
Market Cap Growth | -21.54% | -49.07% | -16.64% | 17.37% | -6.76% | 78.47% |
Enterprise Value | 29.22 | 24.83 | 36.86 | 46.51 | 41.31 | 44.35 |
Last Close Price | 2.41 | 2.71 | 3.75 | 4.60 | 4.00 | 4.29 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.25 | 38.71 | 19.74 | 27.06 | 44.44 | - |
Forward PE | - | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 |
PS Ratio | 0.79 | 0.63 | 1.29 | 1.60 | 1.70 | 1.97 |
PB Ratio | 0.90 | 0.73 | 1.99 | 2.58 | 2.37 | 2.68 |
P/TBV Ratio | 1.63 | 1.83 | 2.93 | 3.93 | 3.70 | 4.27 |
P/FCF Ratio | - | - | 7.48 | 14.64 | 19.93 | - |
P/OCF Ratio | - | - | 6.61 | 13.93 | 15.43 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.02 | 0.87 | 1.33 | 1.75 | 1.93 | 2.24 |
EV/EBITDA Ratio | 5.91 | 5.02 | 7.71 | 7.32 | 11.21 | 26.78 |
EV/EBIT Ratio | 19.05 | 16.19 | 20.34 | 22.52 | 43.49 | - |
EV/FCF Ratio | - | - | 7.76 | 15.96 | 22.66 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.55 | 0.55 | 0.30 | 0.42 | 0.56 | 0.74 |
Debt / EBITDA Ratio | 2.79 | 2.79 | 1.17 | 1.14 | 2.46 | 6.54 |
Debt / FCF Ratio | - | - | 1.17 | 2.48 | 4.96 | - |
Net Debt / Equity Ratio | 0.27 | 0.27 | 0.04 | 0.18 | 0.27 | 0.36 |
Net Debt / EBITDA Ratio | 1.36 | 1.36 | 0.13 | 0.47 | 1.13 | 3.15 |
Net Debt / FCF Ratio | -0.69 | -0.69 | 0.13 | 1.02 | 2.29 | -6.23 |
Asset Turnover | 0.74 | 0.74 | 0.87 | 0.82 | 0.65 | 0.66 |
Inventory Turnover | 3.42 | 3.42 | 3.07 | 1.83 | 2.09 | 2.80 |
Quick Ratio | 3.40 | 3.40 | 2.19 | 2.39 | 2.59 | 2.70 |
Current Ratio | 3.61 | 3.61 | 2.37 | 2.57 | 2.78 | 2.89 |
Return on Equity (ROE) | 3.34% | 3.74% | 6.44% | 9.35% | 5.04% | -2.72% |
Return on Assets (ROA) | 4.03% | 4.03% | 5.81% | 6.46% | 2.97% | -1.33% |
Return on Invested Capital (ROIC) | 4.91% | 6.11% | 9.35% | 10.28% | 4.83% | -2.17% |
Return on Capital Employed (ROCE) | 4.83% | 4.83% | 7.34% | 8.14% | 3.67% | -1.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.12% | 2.58% | 5.07% | 3.70% | 2.25% | - |
FCF Yield | - | - | 13.36% | 6.83% | 5.02% | - |
Buyback Yield / Dilution | - | -31.41% | -2.25% | -2.06% | 0.00% | -28.96% |
Total Shareholder Return | - | -31.41% | -2.25% | -2.06% | 0.00% | -28.96% |